Wisevoter
U.S.

HealthTech Bio Actives Acquired Ingredient Firm Specnova

The acquisition aims to expand the company's presence in the United States and enhance its ingredient delivery platforms.

Updated on Oct. 6, 2026 in Healthcare

Bold flat-color editorial illustration showing uniform spheres in a triangular arrangement, representing advanced bioactive ingredient delivery technology.
HealthTech Bio Actives has finalized its acquisition of Specnova, a move designed to expand the company's ingredient delivery presence in the United States. AI Illustration. Upload story photo >

Live Poll

Do you believe corporate acquisitions generally lead to better product choices for your household?

HealthTech Bio Actives has finalized its acquisition of Specnova, a firm specializing in advanced ingredient delivery technologies. Both companies will continue to operate independently while collaborating on new ingredient solutions.

Why it matters

This strategic move allows HealthTech Bio Actives to enter the United States market by leveraging Specnova's specialized delivery systems. The partnership intends to improve product performance through enhanced encapsulation methods.

The deal combines HealthTech Bio Actives' citrus and vitamin B12 portfolio with Specnova's proprietary delivery platforms. These technologies include LipoVantage for liposome encapsulation and NovaQSpheres, which utilize multilayered beadlets.

The players

HealthTech Bio Actives

This company produces citrus flavonoids and vitamin B12 and is expanding into the United States market.

Specnova

Founded in 2017, this firm specializes in advanced ingredient delivery technologies including liposome and beadlet platforms.

The details

Specnova, founded in 2017, provides technology like the NovaQSpheres platform, which recently powered the January 2025 launch of BodyTech Elite Creatine Beadlets. The companies plan to demonstrate their capabilities at the upcoming SupplySide Global 2026 event.

Timeline

  1. Specnova was established in 2017.

  2. BodyTech Elite Creatine Beadlets debuted in January 2025.

  3. The acquisition was officially announced on October 6, 2026.

  4. The firms will exhibit at SupplySide Global 2026 from October 28 to October 30, 2026.

Market Landscape

The consolidation reflects a broader trend of ingredient suppliers seeking proprietary delivery technologies to differentiate their product offerings. By integrating the NovaQSpheres multilayered beadlet technology, the firm is better positioned to compete in the high-performance supplement market.

Consumers can expect to see more products using advanced encapsulation technologies like LipoVantage on store shelves soon. These innovations are designed to improve the delivery and effectiveness of nutritional ingredients in daily supplements.

The takeaway

The acquisition demonstrates the rising value of specialized delivery platforms in the competitive health supplement sector. Companies that successfully integrate these technologies may offer consumers products with more precise ingredient release profiles.

What happens next

HealthTech Bio Actives will launch its Leanara product in the United States during the SupplySide Global 2026 event, scheduled for October 28-30, 2026, in Las Vegas, Nevada.

Further reading

For more on shifts in the industry, visit the Healthcare section.

Source note: This article includes information reported by Nutritioninsight.

Live Poll

Do you believe corporate acquisitions generally lead to better product choices for your household?